We comprehensively explore the functional significance of altered SGO1 expression levels in pan-cancer from the perspectives of gene expression, prognosis value, genetic alterations, tumor immune micro-environment, genomic heterogeneity, SGO1-related genes and interaction protein networks, as well as enrichment analysis. The gene discussed is SGO1; the disease is neoplasm.